• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
JING Rongyue,XU Lei,XU Chengsong,XU Meimei,GUO Liang,CHEN Yueyue.Clinical observation on the effect of Simiao Powder on coagulation index in the treatment of acute gouty arthritis[J].Journal Of Pharmaceutical Research,2022,41(2):127-130[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2607times   Download 2042次 QR Code for this article
Scan with your phone!
四妙散加减治疗急性痛风性关节炎对凝血指标影响的临床研究
景嵘月,徐蕾,徐长松,徐媚媚,郭亮,陈月月
Font:Larger+|Default|Smaller-
(南京中医药大学附属南京中医院,江苏 南京 210000)
摘要:
目的 本研究旨在探讨四妙散加减治疗急性痛风性关节炎(GA)对凝血指标的影响。方法 选取痛风性关节炎急性发作期湿热蕴结证患者32例,分为治疗组17例、对照组15例,另选取痛风性关节炎间歇期患者12例,设为间歇期对照组,3组患者均予低嘌呤饮食,对照组给予依托考昔、青鹏软膏,治疗组在对照组用药基础上加用四妙散加减,连续用药7 d。间歇期对照组无需药物治疗。治疗组、对照组分别在治疗前后检测以及间歇期对照组检测血小板(PLT)、平均血小板分布宽度(MPR)、平均血小板分布宽度与血小板计数的比值(PPR)、纤维蛋白原(FBG)、D-二聚体(D-D)、C-反应蛋白(CRP)、红细胞沉降率(ESR),治疗组、对照组治疗后评估关节肿痛缓解时间以及治疗效果。所有统计分析采用SPSS统计软件,以P<0.05为差异有统计学意义。结果 痛风性关节炎急性发作期治疗前,治疗组、对照组与间歇期对照组相比在血小板、平均血小板分布宽度、纤维蛋白原、D-二聚体、C-反应蛋白、红细胞沉降率方面均有差异有统计学意义(P<0.01)。痛风性关节炎急性发作期治疗后,对照组和治疗组在血小板、平均血小板分布宽度、纤维蛋白原差异有统计学意义(P<0.01),在关节肿痛缓解时间方面差异有统计学意义(P<0.05)。结论 纤维蛋白原、D-二聚体、血小板以及平均血小板分布宽度、平均血小板分布宽度与血小板计数的比值等凝血指标对急性痛风性关节炎有很大提示作用,四妙散加减有助于降低血小板、平均血小板分布宽度、纤维蛋白原等凝血指标,亦有助于缩短关节肿痛缓解时间,急性痛风性关节炎可辨证选用此方有利于本病的治疗。
关键词:  四妙散  痛风性关节炎  痹症
DOI:10.13506/j.cnki.jpr.2022.02.013
基金项目:
Publication Date:February 25, 2022
Clinical observation on the effect of Simiao Powder on coagulation index in the treatment of acute gouty arthritis
JING Rongyue,XU Lei,XU Chengsong,XU Meimei,GUO Liang,CHEN Yueyue
(Nanjing Hospital of Chinese Medicine affiliated to Nanjing University of Chinese Medicine,Nanjing 210000,China)
Abstract:
Objective This study was to investigate the effect of Simiao Power on coagulation index in the treatment of acute gouty arthritis.Methods Select 32 cases of acute gouty arthritis with damp heat accumulation syndrome, which were divided into the treatment group with 17 cases and the control group with 15 cases. At the same time, 12 cases in interlude of gouty arthritis were selected as the intermittent control group. Three groups were with low purine food. While the control group were given etoricoxib and Qing peng ointment. The intermittent control group had no drug treatment. Before and after treatment, the treatment group and the control group were both tested PLT, MPR, PPR, FBG, D-D, CRP and ESR in venous blood, while the intermittent control group were also tested the above items only once. After treatment, the relief time and treatment effect of joint swelling and pain were evaluated in the treatment group and the control group.  SPSS statistical software was used for all statistical analysis, and P<0.05 was considered statistically significant.Results Before treatment of acute gouty arthritis, there were statistically significant differences in PLT, MPR, FBG, D-D, CRP and ESR in the treatment group and the control group compared with the intermittent control group (P<0.01).After treatment, there were statistically significant differences in PLT, MPR and FBG between the control group and the treatment group (P<0.01), and there were also statistically significant differences in the relief time of joint swelling and pain between the two groups (P<0.05).Conclusion FBG, D-D, PLT, MPR, PPR and other coagulation indicators have a significant role in acute gout arthritis. The supplemented formule of Simiao Powder can reduce PLT, MPR, FBG and other coagulation indicators, and it can also shorten the relief time of joint swelling and pain. Acute gout arthritis can use this prescription for the treatment.
Key words:  Simiao Power  Gouty arthritis  Bi syndrome
Today's Visits:465    Total Visits:2383161
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.